Ginkgo Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Ginkgo Bioworks Holdings
DNA Stock  USD 7.77  0.80  11.48%   
Ginkgo Bioworks financial statements provide useful quarterly and yearly information to potential Ginkgo Bioworks Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ginkgo Bioworks financial statements helps investors assess Ginkgo Bioworks' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ginkgo Bioworks' valuation are summarized below:
Gross Profit
182.5 M
Profit Margin
(2.41)
Market Capitalization
404.5 M
Enterprise Value Revenue
1.3683
Revenue
227 M
We have found one hundred twenty available fundamental trends for Ginkgo Bioworks Holdings, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Ginkgo Bioworks Holdings regular market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. As of March 18, 2025, Market Cap is expected to decline to about 484.1 M. In addition to that, Enterprise Value is expected to decline to about 367.5 M

Ginkgo Bioworks Total Revenue

256.83 Million

Check Ginkgo Bioworks financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ginkgo Bioworks' main balance sheet or income statement drivers, such as Net Interest Income of 21.3 M, Interest Income of 23 M or Depreciation And Amortization of 40.5 M, as well as many indicators such as Price To Sales Ratio of 2.13, Dividend Yield of 0.0 or PTB Ratio of 0.68. Ginkgo financial statements analysis is a perfect complement when working with Ginkgo Bioworks Valuation or Volatility modules.
  
Check out the analysis of Ginkgo Bioworks Correlation against competitors.

Ginkgo Bioworks Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.7 B1.4 B1.1 B
Slightly volatile
Short and Long Term Debt Total460.7 M438.8 M112 M
Slightly volatile
Other Current Liabilities72.8 M65.4 M50.5 M
Slightly volatile
Total Current Liabilities126.9 M107.3 M73.7 M
Slightly volatile
Total Stockholder Equity1.1 B716.1 M721.8 M
Slightly volatile
Other Liabilities224.8 M249.3 M172.2 M
Slightly volatile
Net Tangible Assets1.1 B1.8 B800.8 M
Slightly volatile
Property Plant And Equipment Net374.2 M598.2 M186.5 M
Slightly volatile
Accounts Payable10.7 M14.2 M5.7 M
Slightly volatile
Cash962 M561.6 M666.7 M
Slightly volatile
Non Current Assets Total606.7 M774.7 M349 M
Slightly volatile
Non Currrent Assets Other47.4 M55.3 M24.4 M
Slightly volatile
Other Assets107.1 M102 M33.9 M
Slightly volatile
Cash And Short Term Investments962 M561.6 M666.7 M
Slightly volatile
Net Receivables20.8 M21.9 M25.3 M
Slightly volatile
Common Stock Shares Outstanding49.3 M51.9 M1.1 B
Slightly volatile
Liabilities And Stockholders Equity1.7 B1.4 B1.1 B
Slightly volatile
Non Current Liabilities Total411.5 M554.1 M253.4 M
Slightly volatile
Capital Surpluse7.4 B7.1 B2.4 B
Slightly volatile
Other Current Assets22.6 M19.3 M14.2 M
Slightly volatile
Other Stockholder Equity4.5 B6.6 B2.3 B
Slightly volatile
Total Liabilities538.4 M661.4 M327.2 M
Slightly volatile
Total Current Assets1 B602.7 M710.7 M
Slightly volatile
Cash And Equivalents1 B1.5 B753.6 M
Slightly volatile
Intangible Assets54.1 M72.5 M24 M
Slightly volatile
Common Stock4.8 K5 K92.4 K
Pretty Stable
Property Plant Equipment864 M822.9 M251 M
Slightly volatile
Current Deferred Revenue40.9 M27.7 M32.2 M
Slightly volatile
Capital Lease Obligations255.8 M467.7 M99.3 M
Slightly volatile
Net Invested Capital1.2 B716.1 M709 M
Slightly volatile
Long Term Investments71.2 M48.5 M96.7 M
Slightly volatile
Property Plant And Equipment Gross518 M759 M276.5 M
Slightly volatile
Capital Stock4.8 K5 K123.7 K
Pretty Stable
Non Current Liabilities Other15.7 M16.6 M19.4 M
Slightly volatile
Net Working Capital728.3 M495.5 M550.9 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity49.6 M55.8 M60.9 M
Slightly volatile
Common Stock Total Equity193.1 K218.5 K170.2 K
Slightly volatile
Deferred Long Term Liabilities192.2 M201 M177.5 M
Slightly volatile

Ginkgo Bioworks Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income23 M38.6 M12.5 M
Slightly volatile
Depreciation And Amortization40.5 M63 M22.4 M
Slightly volatile
Interest Expense89.3 K94 K1.8 M
Slightly volatile
Selling General Administrative233.9 M246.2 M218.2 M
Slightly volatile
Total Revenue256.8 M227 M134.1 M
Slightly volatile
Gross Profit175.8 M188.5 M101.4 M
Slightly volatile
Other Operating Expenses1.3 B786.8 M593.7 M
Slightly volatile
Research Development634.9 M424.1 M310.3 M
Slightly volatile
Total Operating Expenses1.2 B748.3 M561 M
Slightly volatile
Reconciled Depreciation43.3 M63 M23.5 M
Slightly volatile
Non Operating Income Net Other70 M78.8 M85.9 M
Slightly volatile
Selling And Marketing Expenses76.8 M86.4 M94.2 M
Slightly volatile

Ginkgo Bioworks Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation106.7 M112.3 M249.6 M
Slightly volatile
Begin Period Cash Flow924.7 M989.6 M489.7 M
Slightly volatile
Depreciation42.7 M63 M23.3 M
Slightly volatile
Capital Expenditures53.6 M62.5 M34.1 M
Slightly volatile
End Period Cash Flow997.7 M605.7 M682.9 M
Slightly volatile
Change To Netincome2.2 B2.1 B640.5 M
Slightly volatile
Dividends Paid838.8 K882.9 K1.1 B
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.132.2445144
Slightly volatile
PTB Ratio0.680.711716.3381
Slightly volatile
Days Sales Outstanding33.3835.137976.387
Slightly volatile
Book Value Per Share13.1113.798322.5339
Very volatile
Stock Based Compensation To Revenue0.470.49481.926
Slightly volatile
Capex To Depreciation0.940.99241.9033
Slightly volatile
PB Ratio0.680.711716.3381
Slightly volatile
EV To Sales1.621.7036137
Slightly volatile
Inventory Turnover1.1 K1.1 K218
Slightly volatile
Days Of Inventory On Hand0.340.3645.1216
Slightly volatile
Payables Turnover2.582.72073.6769
Slightly volatile
Sales General And Administrative To Revenue1.171.08420.982
Slightly volatile
Research And Ddevelopement To Revenue1.71.86781.9278
Slightly volatile
Capex To Revenue0.350.27550.3708
Slightly volatile
Cash Per Share10.2810.821420.2522
Pretty Stable
Days Payables Outstanding124134246
Slightly volatile
Income Quality0.30.58420.373
Pretty Stable
Intangibles To Total Assets0.03460.05260.0252
Slightly volatile
Net Debt To EBITDA0.240.25353.1534
Slightly volatile
Current Ratio9.425.619210.7189
Slightly volatile
Tangible Book Value Per Share11.7812.40121.4269
Very volatile
Receivables Turnover10.9110.38776.5834
Slightly volatile
Shareholders Equity Per Share13.1113.798322.227
Very volatile
Debt To Equity0.640.61280.1453
Slightly volatile
Capex Per Share1.41.20520.9981
Slightly volatile
Revenue Per Share4.34.37513.5625
Slightly volatile
Interest Debt Per Share4.348.45682.9766
Pretty Stable
Debt To Assets0.330.31850.0865
Slightly volatile
Operating Cycle33.3835.137981.4835
Pretty Stable
Price Book Value Ratio0.680.711716.3381
Slightly volatile
Days Of Payables Outstanding124134246
Slightly volatile
Ebt Per Ebit1.20.97811.4266
Slightly volatile
Company Equity Multiplier1.221.92371.4471
Pretty Stable
Total Debt To Capitalization0.40.37990.1064
Slightly volatile
Debt Equity Ratio0.640.61280.1453
Slightly volatile
Quick Ratio9.395.619210.7099
Slightly volatile
Net Income Per E B T1.10.99911.0037
Slightly volatile
Cash Ratio8.695.235310.1774
Slightly volatile
Days Of Inventory Outstanding0.340.3645.1216
Slightly volatile
Days Of Sales Outstanding33.3835.137976.387
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.411.19571.4109
Slightly volatile
Price To Book Ratio0.680.711716.3381
Slightly volatile
Fixed Asset Turnover0.620.37960.8091
Very volatile
Debt Ratio0.330.31850.0865
Slightly volatile
Price Sales Ratio2.132.2445144
Slightly volatile
Asset Turnover0.10.16480.1004
Slightly volatile
Gross Profit Margin0.570.83020.7565
Slightly volatile
Price Fair Value0.680.711716.3381
Slightly volatile

Ginkgo Bioworks Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap484.1 M509.6 M9.2 B
Slightly volatile
Enterprise Value367.5 M386.8 M8.6 B
Slightly volatile

Ginkgo Fundamental Market Drivers

Cash And Short Term Investments561.6 M

Ginkgo Upcoming Events

6th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Ginkgo Bioworks Financial Statements

Ginkgo Bioworks stakeholders use historical fundamental indicators, such as Ginkgo Bioworks' revenue or net income, to determine how well the company is positioned to perform in the future. Although Ginkgo Bioworks investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ginkgo Bioworks' assets and liabilities are reflected in the revenues and expenses on Ginkgo Bioworks' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ginkgo Bioworks Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue27.7 M40.9 M
Total Revenue227 M256.8 M
Cost Of Revenue38.5 M36.6 M
Stock Based Compensation To Revenue 0.49  0.47 
Sales General And Administrative To Revenue 1.08  1.17 
Research And Ddevelopement To Revenue 1.87  1.70 
Capex To Revenue 0.28  0.35 
Revenue Per Share 4.38  4.30 
Ebit Per Revenue(2.47)(2.59)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce
When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:
How To Invest In Ginkgo
Details
Is Ginkgo Stock a good investment?
Details
What is Ginkgo Bioworks' Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Ginkgo Bioworks Correlation against competitors.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.54)
Revenue Per Share
4.375
Quarterly Revenue Growth
0.262
Return On Assets
(0.20)
Return On Equity
(0.60)
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY